Our Science
Rooted in science, we are relentlessly pursuing breakthrough therapies that target the genetic drivers of cancer to transform the lives of patients with cancer and their loved ones.
Rooted in science, we are relentlessly pursuing breakthrough therapies that target the genetic drivers of cancer to transform the lives of patients with cancer and their loved ones.
We are investigating next-generation targeted cancer treatment options, including combination approaches to deepen our understanding of disease biology, overcome resistance mechanisms, and help predict how patient may respond to treatment.
Our experienced researchers and drug developers have an unrelenting curiosity for discovery and a commitment to translating science into therapies that could mean renewed hope for patients with cancer. The breadth of our scientific expertise and discovery platforms allows us to boldly target cancer directly and the environment it lives in.
We are uncovering ways to target prolific tumor mutations and create meaningful breakthroughs for patients with KRAS-mutant, checkpoint inhibitor–resistant and other genetically altered tumors.
Our innovative approaches to drug discovery and development are showcased at conferences and medical meetings and published in peer-reviewed journals.